Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A fluke diagnosis.
Toms C, Morgan SM, Samaan MA, Anderson S. Toms C, et al. Among authors: anderson s. BMJ Case Rep. 2016 Sep 12;2016:bcr2016216169. doi: 10.1136/bcr-2016-216169. BMJ Case Rep. 2016. PMID: 27620553 Free PMC article. No abstract available.
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres.
Samaan MA, Pavlidis P, Johnston E, Warner B, Digby-Bell J, Koumoutsos I, Fong S, Goldberg R, Patel K, Gulati S, Medcalf L, Sastrillo M, Brown-Clarke C, Bidewell-Sullivan J, Forsyth K, Lee E, Stanton A, Duncan J, Chung-Faye G, Dubois P, Powell N, Anderson S, Sanderson J, Hayee B, Irving PM. Samaan MA, et al. Among authors: anderson s. Frontline Gastroenterol. 2017 Jul;8(3):196-202. doi: 10.1136/flgastro-2016-100720. Epub 2016 Aug 10. Frontline Gastroenterol. 2017. PMID: 28839909 Free PMC article.
Refractory coeliac disease: or is it?
Amadi C, Anderson S. Amadi C, et al. Among authors: anderson s. BMJ Case Rep. 2017 Sep 19;2017:bcr2017219271. doi: 10.1136/bcr-2017-219271. BMJ Case Rep. 2017. PMID: 28928249 Free PMC article.
Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centres.
Samaan MA, Pavlidis P, Digby-Bell J, Johnston EL, Dhillon A, Paramsothy R, Akintimehin AO, Medcalf L, Chung-Faye G, DuBois P, Koumoutsos I, Powell N, Anderson SHC, Sanderson J, Hayee BH, Irving PM. Samaan MA, et al. Frontline Gastroenterol. 2018 Jul;9(3):221-231. doi: 10.1136/flgastro-2017-100895. Epub 2017 Oct 11. Frontline Gastroenterol. 2018. PMID: 30047549 Free PMC article.
Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study.
Samaan MA, Forsyth K, Segal JP, De Jong D, Vleugels JLA, Elkady S, Kabir M, Campbell S, Kok K, Armstrong DG, Penez L, Arenaza AP, Seward E, Vega R, Mehta S, Rahman F, McCartney S, Bloom S, Patel K, Pollok R, Westcott E, Darakhshan A, Williams A, Koumoutsos I, Ray S, Mawdsley J, Anderson S, Sanderson JD, Dekker E, D'Haens GR, Hart A, Irving PM. Samaan MA, et al. Among authors: anderson s. J Crohns Colitis. 2019 May 27;13(6):735-743. doi: 10.1093/ecco-jcc/jjy225. J Crohns Colitis. 2019. PMID: 30590513
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response.
Samaan MA, Birdi S, Morales MS, Honap S, Tamilarasan AG, Cunningham G, Koumoutsos I, Ray S, Mawdsley J, Anderson SHC, Sanderson J, Irving PM. Samaan MA, et al. Among authors: anderson shc. Frontline Gastroenterol. 2019 Jul 11;11(3):188-193. doi: 10.1136/flgastro-2019-101259. eCollection 2020. Frontline Gastroenterol. 2019. PMID: 32419909 Free PMC article.
Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL study.
Samaan MA, Cunningham G, Tamilarasan AG, Beltran L, Pavlidis P, Ray S, Mawdsley J, Anderson SH, Sanderson JD, Arkir Z, Irving PM. Samaan MA, et al. Among authors: anderson sh. Aliment Pharmacol Ther. 2020 Jul;52(2):292-302. doi: 10.1111/apt.15808. Epub 2020 Jun 7. Aliment Pharmacol Ther. 2020. PMID: 32506695 Clinical Trial.
6,646 results